Skip to main content
Figure 2 | Respiratory Research

Figure 2

From: Treatment and outcome of patients with metastatic NSCLC: a retrospective institution analysis of 493 patients

Figure 2

Overall survival according to applied lines of systemic therapy. Survival rates were calculated from date of diagnosis. Median survival significantly improved with increasing numbers of lines of systemic therapy (p < 0.001). Patients with 0–6 lines of systemic treatment had a median survival of 2.0, 5.3, 8.7, 13.0, 14.1, 21.8, and 39.1 months, respectively.

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us